{"schema_version":"secwatch.filing_event.v1","accession":"0001612630-24-000003","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.254258+00:00","generated_at":"2026-06-03T00:33:09.237681+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Joint Corp Q1 rev $29.7M (+5% YoY), operating income $1.1M, reiterates guidance","bullets":["Revenue $29.7M (+5% YoY); operating income $1.1M vs loss $653k; net income $0.06/diluted share.","Adjusted EBITDA $3.5M (+75% from $2.0M); system-wide comp sales +3%.","Opened 23 franchised clinics; total clinic count 954; sold 15 franchise licenses, triple Q4 2023's 5.","FY 2024 guidance reiterated: system-wide sales $530-545M, new franchised openings 60-75 (excl. refranchising).","Hired investment bank specializing in refranchising to accelerate corporate clinic portfolio transition."],"urls":{"canonical":"https://secwatch.observer/filing/0001612630-24-000003","json":"https://secwatch.observer/filing/0001612630-24-000003.json","markdown":"https://secwatch.observer/filing/0001612630-24-000003.md","text":"https://secwatch.observer/filing/0001612630-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/0001612630-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/jynt-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:33:09.237681+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7172e6b971275d651a698431415b70155c78c5ef","claim":"JOINT Corp reported Q1 2024 results: revenue $29.7 million, net income $947,000, EPS $0.06 per diluted share. Guidance reaffirmed.","evidence_excerpt":"franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2024. Financial Highlights: Q1 2024 Compared to Q1 2023 • Grew revenue 5% to $29.7 million. • Recorded operating income of $1.1 million, compared to operating loss of $653,000. • Reported net income of $947,000, compared to $2.3 million, including the receipt of the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/0001612630-24-000003-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q1 2024"},{"label":"Revenue","value":"$29.7 million"},{"label":"Net income","value":"$947,000"},{"label":"EPS","value":"$0.06 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}